Antiparkinsonian drugs and visual hallucinations

Lancet Neurol. 2006 Jan;5(1):18-9; author reply 19-20. doi: 10.1016/S1474-4422(05)70267-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Hallucinations / chemically induced*
  • Humans
  • Parkinson Disease / diagnosis
  • Parkinson Disease / drug therapy

Substances

  • Antiparkinson Agents